fbpx

We nurture and develop
multidisciplinary startup teams
that harness emerging tech
to create businesses with
global impact.

D3 Bio

Founders leveraging biomanufacturing and bioengineering looking to accelerate their commercialization potential and contribute to building Canada’s bioeconomy in sectors such as biopharma, agri-food, clean technologies and biomaterials.

D3 Healthcare

Early stage medtech and healthtech startups looking to gain market insights, validate clinical and market needs, accelerate product development, find funding and access international networks.

D3 High Tech

Early stage startups focusing on emerging technologies looking to accelerate their path towards commercialization through coaching, lean entrepreneurship skill development, targeted ecosystem connections and global market expansion support. 

D3 Social

Early stage startups focused on education, health, environment, culture or other social issues with positive impact on the community and the world looking  for support in roadmap development, funding strategy and global market expansion.

We bridge the knowledge,
skills, and resource gap
between building a
product and building a
company.

Our Impact

750
Startups
$20M
Financing Raised
& Sales in 2019
42%
Startups with
Female Founders
82%
Startups with
Immigrant Founders
85%
Startups with
Graduate-Level
Founders
12,000
Community Members

Where To Find Us

Our districts are intertwined networks of physical and digital spaces.

Our Footprint

100+
Startups Exposed to
Global Mindset
30+
Partners
20+
Cities

I had been a scientist all my life. Patents and papers have a major impact only when they become a product, therapy, or tool. I’ve grown tremendously since thanks to the right support to guide me along my entrepreneurial journey.”

Margaret Magdesian, Ph.D., Co-founder of Ananda Devices

Latest News

  • D3 startup BioponixAg’s technology is featured in Journal de Montreal
    D3 startup BioponixAg's Technology is featured in Journal de Montreal.
  • D3 startup Modelis discusses building a drug discovery platform with Technoparc
    Founded in July 2018, Modelis is building a drug discovery platform that uses data, artificial intelligence (AI), machine learning (ML),…
  • The D3 Startup Entrepreneur Competency Model is now available in French
    Learn about the right-sized entrepreneurship skills you need to become an intentional entrepreneur, now available in French.